Scholarlink

<p>Large studies investigating asthma as a potential adverse event of anti-TNFα drugs are lacking. In our study, asthma was more likely to be reported with anti-TNFα drugs compared to biologics and small molecules in RA but exclusively with adalimumab.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Asthma Reporting with Anti-TNFα Drugs used in Inflammatory Joint Diseases: A Vigibase® Study with Disproportionality Analysis

  • 期刊论文

  • 发表日期：

    2026年3月27日

查看全文
  • Matthias Nocenti,
  • François Montastruc,
  • Yannick Degboe,
  • Laurent Guilleminault

摘要

Large studies investigating asthma as a potential adverse event of anti-TNFα drugs are lacking. In our study, asthma was more likely to be reported with anti-TNFα drugs compared to biologics and small molecules in RA but exclusively with adalimumab.